Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +18.84%
#2 Storj Storj +13.26%
#3 Fake World Assets Fake World Assets +7.59%
#4 OriginTrail OriginTrail +6.03%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +5.44%
#6 Geodnet Geodnet +5.34%
#7 Collector Crypt Collector Crypt +5.18%
#8 ApeX ApeX +4.55%
#9 OSK OSK +4.40%
#10 Ardor Ardor +4.39%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Rang in aandelen #20781
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Aandeelprijs
$0.8657
Laatst gesynchroniseerd: 2022-01-26
Marktkapitalisatie
$122.22M
Verandering (1 dag)
-0.88%
Verandering (1 jaar)
0.00%
Land
US
Handel ZIOPHARM Oncology, Inc. (ZIOP)

Categorie

Healthcare
Prijs ZIOP met de marktkapitalisatie van B
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
$0.8657
Marktkapitalisatie van ZIOPHARM Oncology, Inc.(ZIOP)
Marktkapitalisatie: $122.22M
Vanaf August 2026 heeft ZIOPHARM Oncology, Inc. een marktkapitalisatie van $122.22M. Dit maakt ZIOPHARM Oncology, Inc. volgens onze gegevens het 20781st meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van ZIOPHARM Oncology, Inc. van 2006 tot 2026
ZIOP vergeleken met de top 5 populairste stocks
Prijs voor ZIOP Aandeel B Marktkapitalisatie van B uitslagen
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$36,911.68 $122.22M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,263,695.77%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$32,204.21 $122.22M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,719,919.96%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$29,482.46 $122.22M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,405,521.01%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$25,447.43 $122.22M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +2,939,420.54%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$19,781.55 $122.22M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,284,935.02%